Drug Type Small molecule drug |
Synonyms HT 6283, HT6283 |
Target |
Action inhibitors |
Mechanism NEK7 inhibitors(NIMA related kinase 7 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuroinflammation | Preclinical | United States | 23 Nov 2023 |





